Marker Therapeutics, Inc.
MRKR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $17,590 | $10,462 | $13,693 | $19,192 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1,665 | $1,674 | $2,459 | $2,347 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,480 | $1,353 | $841 | $0 |
| Total Curr. Assets | $21,735 | $14,768 | $16,993 | $22,023 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $0 | $0 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $21,735 | $14,768 | $16,993 | $22,023 |
| Liabilities | – | – | – | – |
| Payables | $0 | $1,715 | $1,297 | $1,066 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $63 | $142 | $104 |
| Deferred Revenue | $1,353 | $1,353 | $0 | $0 |
| Other Curr. Liab. | $1,993 | $65 | $44 | $87 |
| Total Curr. Liab. | $3,346 | $4,277 | $2,501 | $3,464 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $3,346 | $4,277 | $2,501 | $3,464 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $17 | $11 | $11 | $11 |
| Retained Earnings | -$457,478 | -$455,479 | -$451,463 | -$447,017 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $475,850 | $0 | $0 | $0 |
| Total Equity | $18,389 | $10,490 | $14,492 | $18,558 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $21,735 | $14,768 | $16,993 | $22,023 |
| Net Debt | -$17,590 | -$10,462 | -$13,693 | -$19,192 |